MoneyWorks4Me

Shalby gains on commencing treatment of COVID-19 patients at Shalby Multi-Specialty Hospital

06 Jul 2020 Evaluate

Shalby is currently trading at Rs. 69.95, up by 0.45 points or 0.65% from its previous closing of Rs. 69.50 on the BSE.

The scrip opened at Rs. 67.40 and has touched a high and low of Rs. 71.00 and Rs. 67.40 respectively. So far 8131 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 123.05 on 04-Nov-2019 and a 52 week low of Rs. 40.05 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 72.25 and Rs. 67.40 respectively. The current market cap of the company is Rs. 764.71 crore.

The promoters holding in the company stood at 79.44%, while Institutions and Non-Institutions held 4.33% and 16.23% respectively.

Shalby has commenced treatment of COVID-19 patients at Shalby Multi-Specialty Hospital at Surat. Pursuant to the requisition order by commissioner of Surat Municipal Corporation under the Epidemic Diseases Act, 1897, 75 beds has been designated for COVID patients / suspected cases of COVID-19 at Shalby Multispecialty Hospital, and the remaining beds are available for Non-COVID patients.

Shalby is a chain of Multi-specialty tertiary care hospitals based out of Ahmedabad. It has combined bed strength of more than 700 beds with its multispecialty hospitals across Gujarat and Goa.

 

Peers